Victoria Head

1PUBLICATIONS
16CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 11, 2022
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C.

Andreas Weiss, Edwige Lorthiois, Louise Barys

Pageof 1

Frequent Collaborators

1 joint publications

Kim S Beyer

1 joint publications

Claudio Bomio-Confaglia

1 joint publications

Ruben de Kanter

1 joint publications

Carmine Fedele

1 joint publications

Eloísa Jiménez Núñez

1 joint publications

Jeffrey D Kearns

1 joint publications

Nils Ostermann

1 joint publications

Johannes Ottl

1 joint publications

Christian Schnell

1 joint publications

Rowan Stringer

Frequent Collaborators

1 joint publications

Kim S Beyer

1 joint publications

Claudio Bomio-Confaglia

1 joint publications

Ruben de Kanter

1 joint publications

Carmine Fedele

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

677
See more related videos

Top Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

677
See more related videos